{"downloaded": true, "htmlmade": false, "full": {"id": "29739773", "source": "MED", "pmid": "29739773", "pmcid": "PMC5941995", "fullTextIdList": {"fullTextId": "PMC5941995"}, "doi": "10.1182/bloodadvances.2017013052", "title": "Graft-versus-host disease in recipients of male unrelated donor compared with parous female sibling donor transplants.", "authorString": "Kumar AJ, Kim S, Hemmer MT, Arora M, Spellman SR, Pidala JA, Couriel DR, Alousi AM, Aljurf MD, Cahn JY, Cairo MS, Cutler CS, Farhan S, Gergis U, Hale GA, Hashmi SK, Inamoto Y, Kamble RT, Kharfan-Dabaja MA, MacMillan ML, Marks DI, Nakasone H, Norkin M, Qayed M, Ringden O, Schouten HC, Schultz KR, Solh MM, Teshima T, Urbano-Ispizua A, Verdonck LF, Gale RP, Hamilton BK, Majhail NS, Loren AW.", "authorList": {"author": [{"fullName": "Kumar AJ", "firstName": "Anita J", "lastName": "Kumar", "initials": "AJ", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Tufts Medical Center, Boston, MA."}}}, {"fullName": "Kim S", "firstName": "Soyoung", "lastName": "Kim", "initials": "S", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Center for International Blood and Marrow Transplant Research, Department of Medicine, and."}, {"affiliation": "Institute for Health and Society, Department of Biostatistics, Medical College of Wisconsin, Milwaukee, WI."}]}}, {"fullName": "Hemmer MT", "firstName": "Michael T", "lastName": "Hemmer", "initials": "MT", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Center for International Blood and Marrow Transplant Research, Department of Medicine, and."}}}, {"fullName": "Arora M", "firstName": "Mukta", "lastName": "Arora", "initials": "M", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota Medical Center, Minneapolis, MN."}}}, {"fullName": "Spellman SR", "firstName": "Stephen R", "lastName": "Spellman", "initials": "SR", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Center for International Blood and Marrow Transplant Research, National Marrow Donor Program/Be The Match, Minneapolis, MN."}}}, {"fullName": "Pidala JA", "firstName": "Joseph A", "lastName": "Pidala", "initials": "JA", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL."}}}, {"fullName": "Couriel DR", "firstName": "Daniel R", "lastName": "Couriel", "initials": "DR", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Utah Blood and Marrow Transplant Program, Salt Lake City, UT."}}}, {"fullName": "Alousi AM", "firstName": "Amin M", "lastName": "Alousi", "initials": "AM", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX."}}}, {"fullName": "Aljurf MD", "firstName": "Mahmoud D", "lastName": "Aljurf", "initials": "MD", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Oncology, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia."}}}, {"fullName": "Cahn JY", "firstName": "Jean-Yves", "lastName": "Cahn", "initials": "JY", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Hematology, Centre Hospitalier Universitaire de Grenoble, Grenoble, France."}}}, {"fullName": "Cairo MS", "firstName": "Mitchell S", "lastName": "Cairo", "initials": "MS", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, Department of Pediatrics, New York Medical College, Valhalla, NY."}}}, {"fullName": "Cutler CS", "firstName": "Corey S", "lastName": "Cutler", "initials": "CS", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Center for Hematologic Oncology, Dana-Farber Cancer Institute, Boston, MA."}}}, {"fullName": "Farhan S", "firstName": "Shatha", "lastName": "Farhan", "initials": "S", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Henry Ford Hospital Bone Marrow Transplant Program, Wayne State University, Detroit, MI."}}}, {"fullName": "Gergis U", "firstName": "Usama", "lastName": "Gergis", "initials": "U", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Hematolgic Malignancies & Bone Marrow Transplant, Department of Medical Oncology, New York Presbyterian Hospital/Weill Cornell Medical Center, New York, NY."}}}, {"fullName": "Hale GA", "firstName": "Gregory A", "lastName": "Hale", "initials": "GA", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Hematology/Oncology, Johns Hopkins All Children's Hospital, St. Petersburg, FL."}}}, {"fullName": "Hashmi SK", "firstName": "Shahrukh K", "lastName": "Hashmi", "initials": "SK", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Internal Medicine, Mayo Clinic, Rochester, MN."}}}, {"fullName": "Inamoto Y", "firstName": "Yoshihiro", "lastName": "Inamoto", "initials": "Y", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Fred Hutchinson Cancer Research Center, Seattle, WA."}}}, {"fullName": "Kamble RT", "firstName": "Rammurti T", "lastName": "Kamble", "initials": "RT", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Division of Hematology and Oncology, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX."}}}, {"fullName": "Kharfan-Dabaja MA", "firstName": "Mohamed A", "lastName": "Kharfan-Dabaja", "initials": "MA", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL."}}}, {"fullName": "MacMillan ML", "firstName": "Margaret L", "lastName": "MacMillan", "initials": "ML", "authorId": {"@type": "ORCID", "#text": "0000-0002-0755-0852"}, "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "University of Minnesota Blood and Marrow Transplant Program, Minneapolis, MN."}}}, {"fullName": "Marks DI", "firstName": "David I", "lastName": "Marks", "initials": "DI", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Adult Bone Marrow Transplant, University Hospitals Bristol National Health Service Trust, Bristol, United Kingdom."}}}, {"fullName": "Nakasone H", "firstName": "Hideki", "lastName": "Nakasone", "initials": "H", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Jichi Medical University, Shimotsuke, Japan."}}}, {"fullName": "Norkin M", "firstName": "Maxim", "lastName": "Norkin", "initials": "M", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Division of Hematology/Oncology, University Florida College of Medicine, Gainesville, FL."}}}, {"fullName": "Qayed M", "firstName": "Muna", "lastName": "Qayed", "initials": "M", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Pediatrics, Emory University School of Medicine, Atlanta, GA."}}}, {"fullName": "Ringden O", "firstName": "Olle", "lastName": "Ringden", "initials": "O", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Division of Therapeutic Immunology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden."}}}, {"fullName": "Schouten HC", "firstName": "Harry C", "lastName": "Schouten", "initials": "HC", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Hematology, Academische Ziekenhuis, Maastricht, The Netherlands."}}}, {"fullName": "Schultz KR", "firstName": "Kirk R", "lastName": "Schultz", "initials": "KR", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Pediatric Hematology, Oncology and Bone Marrow Transplant, British Columbia's Children's Hospital, The University of British Columbia, Vancouver, BC, Canada."}}}, {"fullName": "Solh MM", "firstName": "Melhem M", "lastName": "Solh", "initials": "MM", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "The Blood and Marrow Transplant Group of Georgia, Northside Hospital, Atlanta, GA."}}}, {"fullName": "Teshima T", "firstName": "Takanori", "lastName": "Teshima", "initials": "T", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Kyushu University Hospital, Sapporo, Japan."}}}, {"fullName": "Urbano-Ispizua A", "firstName": "Alvaro", "lastName": "Urbano-Ispizua", "initials": "A", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Hematology, Hospital Clinic, University of Barcelona, Institut d'investigacions Biomediques August Pi i Sunyer, and Institute of Research Josep Carreras, Barcelona, Spain."}}}, {"fullName": "Verdonck LF", "firstName": "Leo F", "lastName": "Verdonck", "initials": "LF", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Hematology/Oncology, Isala Clinic, Zwolle, The Netherlands."}}}, {"fullName": "Gale RP", "firstName": "Robert Peter", "lastName": "Gale", "initials": "RP", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Hematology Research Centre, Division of Experimental Medicine, Department of Medicine, Imperial College London, London, United Kingdom."}}}, {"fullName": "Hamilton BK", "firstName": "Betty K", "lastName": "Hamilton", "initials": "BK", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Blood & Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; and."}}}, {"fullName": "Majhail NS", "firstName": "Navneet S", "lastName": "Majhail", "initials": "NS", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Blood & Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; and."}}}, {"fullName": "Loren AW", "firstName": "Alison W", "lastName": "Loren", "initials": "AW", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA."}}}]}, "authorIdList": {"authorId": {"@type": "ORCID", "#text": "0000-0002-0755-0852"}}, "dataLinksTagsList": {"dataLinkstag": "altmetrics"}, "journalInfo": {"issue": "9", "volume": "2", "journalIssueId": "2676483", "dateOfPublication": "2018 May", "monthOfPublication": "5", "yearOfPublication": "2018", "printPublicationDate": "2018-05-01", "journal": {"title": "Blood advances", "ISOAbbreviation": "Blood Adv", "medlineAbbreviation": "Blood Adv", "NLMid": "101698425", "ISSN": "2473-9529", "ESSN": "2473-9537"}}, "pubYear": "2018", "pageInfo": "1022-1031", "abstractText": "Optimal donor selection is critical for successful allogeneic hematopoietic cell transplantation (HCT). Donor sex and parity are well-established risk factors for graft-versus-host disease (GVHD), with male donors typically associated with lower rates of GVHD. Well-matched unrelated donors (URDs) have also been associated with increased risks of GVHD as compared with matched sibling donors. These observations raise the question of whether male URDs would lead to more (or less) favorable transplant outcomes as compared with parous female sibling donors. We used the Center for International Blood and Marrow Transplant Research registry to complete a retrospective cohort study in adults with acute myeloid leukemia, acute lymphoblastic leukemia, or myelodysplastic syndrome, who underwent T-cell replete HCT from these 2 donor types (parous female sibling or male URD) between 2000 and 2012. Primary outcomes included grade 2 to 4 acute GVHD (aGVHD), chronic GVHD (cGVHD), and overall survival. Secondary outcomes included disease-free survival, transplant-related mortality, and relapse. In 2813 recipients, patients receiving male URD transplants (n = 1921) had 1.6 times higher risk of grade 2 to 4 aGVHD (P < .0001). For cGVHD, recipient sex was a significant factor, so donor/recipient pairs were evaluated. Female recipients of male URD grafts had a higher risk of cGVHD than those receiving parous female sibling grafts (relative risk [RR] = 1.43, P < .0001), whereas male recipients had similar rates of cGVHD regardless of donor type (RR = 1.09, P = .23). Donor type did not significantly affect any other end point. We conclude that when available, parous female siblings are preferred over male URDs.", "affiliation": "Tufts Medical Center, Boston, MA.", "publicationStatus": "ppublish", "language": "eng", "pubModel": "Print", "pubTypeList": {"pubType": ["Comparative Study", "Clinical Trial", "Research Support, U.S. Gov't, P.H.S.", "Research Support, Non-U.S. Gov't", "research-article", "Research Support, U.S. Gov't, Non-P.H.S.", "Journal Article", "Research Support, N.I.H., Extramural", "Observational Study"]}, "grantsList": {"grant": [{"grantId": "UL1 TR002378", "agency": "NCATS NIH HHS", "acronym": "TR", "orderIn": "0"}, {"grantId": "U24 CA076518", "agency": "NCI NIH HHS", "acronym": "CA", "orderIn": "0"}, {"grantId": "U10 HL069294", "agency": "NHLBI NIH HHS", "acronym": "HL", "orderIn": "0"}, {"grantId": "KL2 TR002381", "agency": "NCATS NIH HHS", "acronym": "TR", "orderIn": "0"}]}, "meshHeadingList": {"meshHeading": [{"majorTopic_YN": "N", "descriptorName": "Humans"}, {"majorTopic_YN": "Y", "descriptorName": "Myelodysplastic Syndromes", "meshQualifierList": {"meshQualifier": [{"abbreviation": "MO", "qualifierName": "mortality", "majorTopic_YN": "N"}, {"abbreviation": "TH", "qualifierName": "therapy", "majorTopic_YN": "N"}]}}, {"majorTopic_YN": "N", "descriptorName": "Graft vs Host Disease", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ET", "qualifierName": "etiology", "majorTopic_YN": "N"}, {"abbreviation": "MO", "qualifierName": "mortality", "majorTopic_YN": "Y"}]}}, {"majorTopic_YN": "N", "descriptorName": "Disease-Free Survival"}, {"majorTopic_YN": "Y", "descriptorName": "Donor Selection"}, {"majorTopic_YN": "Y", "descriptorName": "Hematopoietic Stem Cell Transplantation"}, {"majorTopic_YN": "Y", "descriptorName": "Registries"}, {"majorTopic_YN": "N", "descriptorName": "Survival Rate"}, {"majorTopic_YN": "Y", "descriptorName": "Siblings"}, {"majorTopic_YN": "N", "descriptorName": "Sex Factors"}, {"majorTopic_YN": "N", "descriptorName": "Adult"}, {"majorTopic_YN": "N", "descriptorName": "Middle Aged"}, {"majorTopic_YN": "N", "descriptorName": "Female"}, {"majorTopic_YN": "N", "descriptorName": "Male"}, {"majorTopic_YN": "Y", "descriptorName": "Precursor Cell Lymphoblastic Leukemia-Lymphoma", "meshQualifierList": {"meshQualifier": [{"abbreviation": "MO", "qualifierName": "mortality", "majorTopic_YN": "N"}, {"abbreviation": "TH", "qualifierName": "therapy", "majorTopic_YN": "N"}]}}, {"majorTopic_YN": "Y", "descriptorName": "Unrelated Donors"}, {"majorTopic_YN": "N", "descriptorName": "Allografts"}]}, "subsetList": {"subset": {"code": "IM", "name": "Index Medicus"}}, "fullTextUrlList": {"fullTextUrl": [{"availability": "Subscription required", "availabilityCode": "S", "documentStyle": "doi", "site": "DOI", "url": "https://doi.org/10.1182/bloodadvances.2017013052"}, {"availability": "Free", "availabilityCode": "F", "documentStyle": "html", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC5941995"}, {"availability": "Free", "availabilityCode": "F", "documentStyle": "pdf", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC5941995?pdf=render"}, {"availability": "Free", "availabilityCode": "F", "documentStyle": "doi", "site": "DOI", "url": "https://doi.org/10.1182/bloodadvances.2017013052"}]}, "commentCorrectionList": {"commentCorrection": {"id": "29891590", "source": "MED", "reference": "Blood Adv. 2018 Jun 12;2(11):1294", "type": "Erratum in", "orderIn": "1"}}, "isOpenAccess": "N", "inEPMC": "Y", "inPMC": "N", "hasPDF": "Y", "hasBook": "N", "hasSuppl": "N", "citedByCount": "4", "hasData": "N", "hasReferences": "Y", "hasTextMinedTerms": "Y", "hasDbCrossReferences": "N", "hasLabsLinks": "Y", "authMan": "N", "epmcAuthMan": "N", "nihAuthMan": "N", "hasTMAccessionNumbers": "N", "dateOfCompletion": "2019-02-21", "dateOfCreation": "2018-05-10", "firstIndexDate": "2018-05-10", "fullTextReceivedDate": "2020-07-14", "dateOfRevision": "2019-04-24", "firstPublicationDate": "2018-05-01"}, "abstract": "Optimal donor selection is critical for successful allogeneic hematopoietic cell transplantation (HCT). Donor sex and parity are well-established risk factors for graft-versus-host disease (GVHD), with male donors typically associated with lower rates of GVHD. Well-matched unrelated donors (URDs) have also been associated with increased risks of GVHD as compared with matched sibling donors. These observations raise the question of whether male URDs would lead to more (or less) favorable transplant outcomes as compared with parous female sibling donors. We used the Center for International Blood and Marrow Transplant Research registry to complete a retrospective cohort study in adults with acute myeloid leukemia, acute lymphoblastic leukemia, or myelodysplastic syndrome, who underwent T-cell replete HCT from these 2 donor types (parous female sibling or male URD) between 2000 and 2012. Primary outcomes included grade 2 to 4 acute GVHD (aGVHD), chronic GVHD (cGVHD), and overall survival. Secondary outcomes included disease-free survival, transplant-related mortality, and relapse. In 2813 recipients, patients receiving male URD transplants (n = 1921) had 1.6 times higher risk of grade 2 to 4 aGVHD (P < .0001). For cGVHD, recipient sex was a significant factor, so donor/recipient pairs were evaluated. Female recipients of male URD grafts had a higher risk of cGVHD than those receiving parous female sibling grafts (relative risk [RR] = 1.43, P < .0001), whereas male recipients had similar rates of cGVHD regardless of donor type (RR = 1.09, P = .23). Donor type did not significantly affect any other end point. We conclude that when available, parous female siblings are preferred over male URDs.", "journaltitle": "Blood advances", "authorinfo": ["Kumar AJ", "Kim S", "Hemmer MT", "Arora M", "Spellman SR", "Pidala JA", "Couriel DR", "Alousi AM", "Aljurf MD", "Cahn JY", "Cairo MS", "Cutler CS", "Farhan S", "Gergis U", "Hale GA", "Hashmi SK", "Inamoto Y", "Kamble RT", "Kharfan-Dabaja MA", "MacMillan ML", "Marks DI", "Nakasone H", "Norkin M", "Qayed M", "Ringden O", "Schouten HC", "Schultz KR", "Solh MM", "Teshima T", "Urbano-Ispizua A", "Verdonck LF", "Gale RP", "Hamilton BK", "Majhail NS", "Loren AW"], "title": "Graft-versus-host disease in recipients of male unrelated donor compared with parous female sibling donor transplants."}